 Blackwell, 1988: 
The inflammatory myopathies are the largest group of acquired myopathies of adult life and may also occur in infancy and childhood. They have in common the presence of inflammatory infiltrates within skeletal muscle, usually in association with muscle fibre destruction. They can be subdivided into those which are due to known viral, bacterial, protozoal or other microbial agents and those in which no such agent can be identified and in which immunological mechanisms have been implicated.' The latter group includes polymyositis, dermatomyositis and inclusion body myositis. The evidence for an autoimmune aetiology consists of: 1) an association with other autoimmune diseases; 2) serological tests which reflect an altered immune state; and 3) the responsiveness of polymyositis and dermatomyositis, if not of the inclusion body variety, to immunotherapy.2 Polymyositis may rarely occur in infancy (infantile myositis) but is commoner in adult life, while dermatomyositis can occur both in children and in adults and is often associated with other connective tissue diseases, with immune deficiency states or with other systemic disorders; in middle or late life there is a statistical association with malignant disease. Both polymyositis and dermatomyositis can sometimes be druginduced.3
Related disorders include sarcoid myopathy and granulomatous myositis (which can only be distinguished from sarcoid myopathy by the absence of evidence of sarcoid in tissues and organs other than muscle), localised nodular myositis,4 eosinophilic polymyositis (which occurs as part of a systemic hypereosinophilic syndrome characterised by eosinophilia, anaemia, hypergammaglobulinaemia, cardiac and pulmonary involvement, skin changes, peripheral neuropathy and encephalopathy5) and eosinophilic perimyositis.67 Focal and relapsing forms of eosinophilic myositis have been described,8 as has a form of angiopathic myositis, sometimes associated with polyarteritis nodosa, Churg-Strauss vasculitis or Wegener's granulomatosis.' Eosinophilic fasciitis may also be confused with the myositic syndrome; in this condition there is painful swelling and induration of the skin and soft tissues of the extremities and trunk leading to weakness and contractures in the limbs, often with a marked eosinophilia in the peripheral blood and hypergammaglobulinaemia.9 A form of eosinophilic fasciitis presenting as a sclerodermalike syndrome, now called the tryptophan-eosinophiliamyalgia syndrome, has also been reported in recent years in patients taking L-tryptophan for the treatment of depression or insomnia'0 but is thought by some to be due to a contaminant in the L-tryptophan rather than to a direct effect of the drug itself. A resemblance has been suggested between this condition and the so-called Spanish toxic oil syndrome." In some such cases a peripheral neuropathy also occurs.'2
As new knowledge has accumulated over the course of the last 10 years, it has become increasingly clear that there are distinct pathological and immunological differences between polymyositis on the one hand and dermatomyositis on the other, though in some cases there is clearly an overlap between the two conditions. In polymyositis there is usually scattered necrosis of single muscle fibres which appear hyalinised in the early stages and are subsequently invaded by mononuclear phagocytic cells. Regenerating fibres are usually seen singly or in small groups distributed focally and randomly throughout the muscle. The inflammatory cell infiltrate is predominantly intrafascicular (endomysial) surrounding muscle fibres rather than in the interfascicular septa, though perivascular infiltrates may also be found; the cellular infiltrate consists mainly of lymphocytes, plasma cells and macrophages. Immunocytochemical studies using monoclonal antibody markers have shown that most of the lymphocytes and the cellular infiltrates are activated T cells with a mixture of CD8 + (suppressor/cytotoxic) and CD4 + (helper/ inducer) cells, as well as macrophages.'3 14 Class 1 MHC antigen expressed on the surface of non-necrotic muscle fibres which are being invaded by lymphocytes supports the view that the muscle fibre damage is caused by cytotoxic T lymphocytes as these cells require the presence of Class 1 MHC molecules on target cells to exert their action.2
In dermatomyositis, particularly in childhood, isolated muscle fibre necrosis is a rare finding; more often, portions of a muscle fasciculus may be necrotic and the lesions resemble micro-infarcts. There is also a typical perifascicular atrophy involving both type 1 and type 2 muscle fibres. Microvascular changes, including capillary loss, necrosis and thrombosis of capillaries, arterioles and venules accounting for the appearances resembling microinfarction are also common.'5 16 Immunoglobulins and complement components, including the C5b-9 membrane attack complex, are commonly found in blood vessel walls, suggesting that the condition is an immune complex vasculopathy. ' have confirmed the beneficial effect of immunosuppressive agents such as azathioprine, methotrexate and cyclophosphamide when given in addition to steroids. Cyclosporin A has proved successful in a few resistant cases, but Grezard and others2' reported that a severe myopathy resulted from cyclosporin treatment in a patient who had previously undergone a renal transplant. Recently Engel and Emslie-Smith' have found intravenous pulsed methyl-prednisolone to be superior in its effects to oral treatment in both polymyositis and dermatomyositis but have suggested that such treatment should only be continued for a few weeks and should be followed by combined oral steroids given on an alternate-day basis with an appropriate immunosuppressive remedy for longer-term maintenance treatment. Yet again, in some resistant cases total body irradiation or total lymphoid irradiation has been recommended and has been found successful by Engel3" and others. More recently Cherin and others,32 writing from Paris, reported strikingly beneficial effects in both polymyositis and dermatomyositis using intravenous immunoglobulin. Ten patients received lg per kg daily for two days each month while five received 0 5g per kg daily for five days each month, the mean course of treatment being four months. This treatment was given with prednisone in 11 cases, methotrexate in five, and plasmapheresis in one. Marked improvement was noted in 13 of the 15 cases so treated; the authors concluded that intravenous immunoglobulin might well be used to replace or reduce steroid and immunosuppressive drug treatment in such cases. Finally, it should be mentioned that in dermatomyositis, following the report of Bennington and Dau in 198133 plasmapheresis has been shown to be effective, but most authorities still reserve this form of treatment for use in severe cases unresponsive to oral steroids and immunosuppressive agents.
The present position therefore appears to be that in both polymyositis and dermatomyositis the treatment of choice is still oral prednisone combined with azathioprine. Once the disease has been brought under control, as demonstrated by clinical and functional assessment and a fall in serum creatine kinase activity, it is reasonable to move to alternate-day treatment with prednisone, while continuing with the azathioprine for 12-18 months, thereafter using prednisone in whatever level of dosage is required to control the clinical manifestations of the disease for as long as may be needed (this may be many years). It is possible that pulsed methyl-prednisolone as an initial treatment may prove superior to oral treatment, but this is still uncertain. The place of intravenous immunoglobulin is still to be evaluated but this is unlikely to be widely used except in resistant cases for as long as it proves to be so horrendously expensive (at present about £C2000 for a course Observations on the anatomy of animals were transferred to the human anatomy but he lamented the prejudice which prevented dissection of the human body. Neurology was the best feature of his anatomical work. Most of the gross structures of the brain were classified by him. He knew of seven pairs of cranial nerves and of the cervical, brachial and lumbar sacral plexuses. The sympathetic ganglia were described as reinforcers of the nerves. His myology was based mainly on the study of the barbary ape. He understood the difference between origin and insertion, and was aware of most muscles and their functions.
Among his brilliant experiments were the demonstrations of the function of the laryngeal nerves, the motor and sensory functions of the spinal nerve roots, and the effect of transverse incision and hemisection of the spinal cord. He knew hydrophobia followed the bite of a mad dog and sometimes maniacal attacks supervened. Galen showed that arteries contained blood and not air and was close to discovering the circulation of the blood. He was the founder of experimental physiology. This Hungarian stamp issued in 1989 is one of a "Pioneers of Medicine" series.
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